Impact of the Platelet Level in Patients Treated for Glioblastoma With Temozolomid
Clinical trial NCT02617745 · COMPLETED
Trial details
- NCT number
- NCT02617745
- Sponsor
- Centre Henri Becquerel
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-30
- Primary completion
- 2022-11-28
- Enrollment
- 244
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.